16. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, et al. (2001) Mitochondrial abnormalities in Alzheimer’s disease. J Neurosci 21: 3017–3023. 17. Rice SE, Gelfand VI (2006) Paradigm lost: milton connects kinesin heavy chain to miro on mitochondria. J Cell Biol 173: 459–461. 18. Frederick RL, Shaw JM (2007) Moving mitochondria: establishing distribution of an essential organelle. Traffic 8: 1668–1675. 19. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, et al. (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417: 455–458. 20. Zhang Y, Li N, Caron C, Matthias G, Hess D, et al. (2003) HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J 22: 1168– 1179. 21. Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, et al. (2010) Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 132: 10842–10846. 22. Silva DF, Esteves AR, Arduino DM, Oliveira CR, Cardoso SM (2011) Amyloid- beta-Induced Mitochondrial Dysfunction Impairs the Autophagic Lysosomal Pathway in a Tubulin Dependent Pathway. J Alzheimers Dis 26(3): 565–581. 23. Varadi A, Johnson-Cadwell LI, Cirulli V, Yoon Y, Allan VJ, et al. (2004) Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J Cell Sci 117: 4389–4400. 24. Anesti V, Scorrano L (2006) The relationship between mitochondrial shape and function and the cytoskeleton. Biochim Biophys Acta 1757: 692–699. 25. Lee JS, Yoon YG, Yoo SH, Jeong NY, Jeong SH, et al. (2011) Histone deacetylase inhibitors induce mitochondrial elongation. J Cell Physiol 227(7): 2856–2869. 26. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, et al. (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease. FASEB J 19: 2040–2041. 27. Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, et al. (2009) Axonal transport defects in neurodegenerative diseases. J Neurosci 29: 12776–12786. 28. Chang DT, Reynolds IJ (2006) Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol 80: 241–268. 29. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, et al. (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105: 19318–19323. Role of HDAC6 Inhibitor in Mitochondrial Transport 30. Lei P, Ayton S, Bush AI, Adlard PA (2011) GSK-3 in Neurodegenerative Diseases. Int J Alzheimers Dis 2011: 189246. 31. Chen S, Owens GC, Makarenkova H, Edelman DB (2010) HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One 5: e10848. 32. d’Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, et al. (2011) HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1- induced Charcot-Marie-Tooth disease. Nat Med 17: 968–974. 33. Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, et al. (2009) Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci 122: 3531–3541. 34. Goldstein LS, Yang Z (2000) Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci 23: 39–71. 35. Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, et al. (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington’s disease by increasing tubulin acetylation. J Neurosci 27: 3571– 3583. 36. Wang X, Perry G, Smith MA, Zhu X (2010) Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener Dis 7: 56–59. 37. Reddy PH (2007) Mitochondrial dysfunction in aging and Alzheimer’s disease: strategies to protect neurons. Antioxid Redox Signal 9: 1647–1658. 38. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60: 748–766. 39. Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH (2010) Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/ Milton complex. J Neurosci 30: 4232–4240. 40. Cha MY, Han SH, Son SM, Hong HS, Choi YJ, et al. (2012) Mitochondria- specific accumulation of amyloid beta induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 7: e34929. 41. Miller KE, Sheetz MP (2004) Axonal mitochondrial transport and potential are correlated. J Cell Sci 117: 2791–2804. 42. Kaech S, Banker G (2006) Culturing hippocampal neurons. Nat Protoc 1: 2406– 2415. 43. Park JW, Vahidi B, Taylor AM, Rhee SW, Jeon NL (2006) Microfluidic culture platform for neuroscience research. Nat Protoc 1: 2128–2136. 44. Boo JH, Song H, Kim JE, Kang DE, Mook-Jung I (2009) Accumulation of phosphorylated beta-catenin enhances ROS-induced cell death in presenilin- deficient cells. PLoS One 4: e4172. PLOS ONE | www.plosone.org 7 August 2012 | Volume 7 | Issue 8 | e42983